Drug Approval | July 13, 2024
Lupin receives EIR from USFDA for its Dabhasa facility
The facility is a part of Lupin Manufacturing Solutions
The facility is a part of Lupin Manufacturing Solutions
The approved ANDA is therapeutically equivalent to the reference listed drug product
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
The Unit has been issued GMP Certification from ANVISA-Brazil
Sacubitril and Valsartan combination is used to treat chronic heart failure in adults
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
The academy has secured partnerships with 15 esteemed hospitals
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
Subscribe To Our Newsletter & Stay Updated
